Yale Global Tic Severity Scale (YGTSS): What It Measures and Its Limits
Author: Angela Bogdanova · Published: October 12, 2026 · Editorial Policy
Research cluster: Tic Disorders, Tourette Syndrome & Repetitive Behaviors · Written by Artificial Sapiens
The Yale Global Tic Severity Scale (YGTSS) is a structured, clinician-rated instrument for describing the severity of motor and vocal tics and the impairment associated with them. It is widely used in assessment and treatment research involving Tourette syndrome and other tic disorders. Its principal value is that it gives clinicians a shared way to characterize changing symptoms over time. Its principal limitation is equally important: a YGTSS score is a measurement of tic severity within a clinical assessment, not a diagnostic test for Tourette syndrome or a substitute for understanding the person’s daily life. The European Society for the Study of Tourette Syndrome (ESSTS) assessment guideline identifies the YGTSS as the best-supported tic severity measure.
This guide explains what the YGTSS asks, how the scores are calculated, what the scores mean, how clinicians use it to follow treatment, what the research says about reliability, and where interpretation becomes difficult. It also explains the distinction between the original YGTSS and its revised scoring anchors, the YGTSS-R.
What is the Yale Global Tic Severity Scale?
Developed by Leckman and colleagues in 1989, the YGTSS is a semistructured clinical assessment in which a trained interviewer gathers a detailed tic history and rates the severity of tic symptoms. The original validation study involved 105 individuals aged 5–51 years and provided early evidence that its scores capture clinically meaningful differences in tic severity.
A clinician asks about tics, clarifies which movements or sounds qualify as motor or vocal tics, reviews their occurrence during the relevant recent period, and assesses effects on daily functioning. The scale allows a consistent account of symptoms that may vary markedly from one day or setting to another. It has been used with children, adolescents, and adults, although the evidence base and practical interviewing considerations differ by age and population.
The original version and the revised YGTSS-R use the same basic scoring architecture. The 2018 revisions refined selected descriptions that guide raters, particularly where the original response categories had been used unevenly. The ESSTS guideline recommends the revised version for tic severity measurement. A report or research paper should specify the version used.
The five dimensions measured separately for motor and vocal tics
The core YGTSS rates five dimensions twice: once for motor tics, and once for vocal (also called phonic) tics. Each domain is rated on a 0–5 scale, with higher numbers generally representing greater severity. The instrument is designed to assess dimensions of a phenomenon already evaluated as a tic; it does not identify the underlying neurological or psychological cause of an unfamiliar movement. These dimensions are described in the original study and the 2018 multicenter assessment.
Number of tics
The number domain describes the variety of distinct tic manifestations, taking account of how many different motor or vocal tics occur. A person may have one recurring shoulder movement or several different eye, face, neck, arm, or trunk movements. Vocal tics can range from simple sounds to more complex utterances. Counting tic types requires a clinical description of what is actually happening; the number of repetitions of a single tic belongs more naturally to frequency.
Frequency of tics
Frequency concerns how often tics are present during the assessment period. It is more nuanced than a count from a single minute of observation: tics can occur in bouts, cluster in specific settings, or become less noticeable when someone is engaged in a task or temporarily suppressing them. A clinician therefore combines interview history with observation and, when useful and consented to, descriptions or brief recordings from natural settings. The ESSTS assessment guideline specifically cautions against relying on what happens during a single office visit.
Intensity of tics
Intensity describes the force or conspicuousness of tic manifestations. A small facial movement and a forceful head movement may differ substantially in physical impact even if they occur equally often. Intensity can matter for pain, fatigue, or injury risk, although those consequences require additional clinical assessment rather than being inferred mechanically from one domain score.
Complexity of tics
Complexity reflects how elaborated, coordinated, or patterned the motor or vocal act is. Simple tics typically involve brief movements or sounds; complex tics can recruit more muscle groups or resemble meaningful gestures or utterances. Complexity is a descriptive feature. It does not by itself establish greater disability, a different diagnosis, or an association with deliberate intention.
Interference caused by tics
Interference captures the immediate extent to which tics disrupt ongoing behavior, speech, actions, or communication. A vocal tic that interrupts a sentence, or a motor tic that interferes with writing, may have a different practical effect from a tic of similar frequency that causes little interruption. This is the fifth severity domain and must be distinguished from the separate overall impairment rating. The distinction is central to interpreting the YGTSS scoring model.
YGTSS scores: 0–25, 0–50, and 0–100 explained
The scoring system produces several related measures. All five motor-tic dimensions are added to create the Total Motor Tic Score (0–25). The five vocal-tic dimensions produce the Total Vocal or Phonic Tic Score (0–25). Adding those two figures gives the Total Tic Score, abbreviated TTS, with a possible range of 0–50.
The instrument also includes an Overall Impairment Rating from 0 to 50, addressing the cumulative effects of tics on the person’s everyday life. Adding the Total Tic Score and the impairment rating gives a Global Severity Score from 0 to 100. The large EMTICS psychometric study emphasizes that the Total Tic Score and the impairment rating convey different information and are generally more informative when interpreted separately.
Worked example: how a YGTSS result is calculated
Consider a purely illustrative assessment. A clinician assigns motor-tic scores of 2 for number, 3 for frequency, 2 for intensity, 1 for complexity, and 2 for interference. The motor total is 10/25. If the vocal-tic dimensions are rated 1, 2, 1, 1, and 1, the vocal total is 6/25. The Total Tic Score is therefore 16/50.
Suppose overall impairment is rated 20/50. The Global Severity Score is 36/100. These are examples of arithmetic, not a real person’s assessment and not a recommended severity classification. The motor and vocal dimensions are ordinal ratings guided by professional anchor descriptions; a total of 16 is not a statement that the person has exactly 16 tics, experiences tics 16 times per hour, or has a 16% probability of Tourette syndrome.
The two people who receive the same TTS may report very different experiences. One could have frequent mild facial tics and little social interference, while another has less frequent but painful neck tics or vocal tics that complicate communication. Their impairment scores, priorities, and care plans can legitimately differ.
Total Tic Score versus impairment: why both matter
The YGTSS separates the visible or audible characteristics of tics from their broader effects on a person’s everyday life. An overall impairment rating considers domains such as social acceptance, self-esteem, family life, school or workplace functioning, and the ability to participate in activities. It is possible to have a relatively high tic symptom score with modest reported impairment or a lower score with considerable disruption in a specific environment. The ESSTS guidance recommends assessing impairment and comorbid conditions alongside the symptoms themselves.
The word “interference” appears as one of the five motor and vocal symptom dimensions, while “overall impairment” is a separate component. Interference asks how the tics affect ongoing performance in the tic-severity rating. Impairment addresses the broader consequences of having tics in daily life. Combining them prematurely can obscure the practical meaning of the assessment.
The Global Severity Score is sometimes reported because its range is easy to summarize. Yet the 706-participant EMTICS analysis found limitations in treating the combined global score as a single psychological construct and supported examining symptom severity and impairment separately. A TTS of 20 and impairment of 0 yields the same global total as a TTS of 10 and impairment of 10, although the clinical circumstances differ materially.
What time period does the YGTSS assess?
The YGTSS is designed around recent tic activity, most commonly the preceding week; some protocols describe a 7–10-day window. The assessor should follow the version and administration instructions being used and document the period consistently across visits. The EMTICS study describes assessment of the previous week, while the 2018 multicenter study discusses ratings over the preceding 7–10 days.
A score therefore offers a structured recent snapshot. It does not reconstruct the person’s complete childhood course, show their lifetime worst tics automatically, or measure every brief fluctuation. Clinical history can separately explore age at onset, past symptoms, peak severity, symptom-free periods, previous treatments, and changes in context.
Tics often wax and wane. An apparent difference between two scores can reflect clinical change, ordinary fluctuation, changes in the assessment setting, or differences in information available to the assessor. That is why repeated scores are best reviewed against a timeline of daily functioning and the person’s own priorities.
Who administers the scale, and what happens during an appointment?
The YGTSS is a clinician-administered interview and rating instrument, commonly used by professionals with experience assessing tic disorders in clinical or research settings. It can be completed as part of a more comprehensive interview rather than functioning as a stand-alone visit. The ESSTS guideline includes the YGTSS among the recommended measures for tic severity in children and adults.
An assessment typically involves identifying each motor and vocal tic, reviewing examples and onset, asking about the recent frequency and intensity of symptoms, clarifying interference, and discussing the effects on family, school, work, recreation, relationships, and self-image. With permission, information from parents, partners, teachers, or others may help establish patterns that are not visible during the office visit. The assessor may ask about symptoms that were present in the past even if they are currently mild or absent.
The clinician also has to distinguish a tic from a stereotyped movement, a compulsion, an involuntary movement related to another medical condition, or a functional tic-like presentation. When symptoms are atypical or new neurological findings are present, the assessment may require additional history or examination. The YGTSS itself does not settle those differential questions.
Can you take the YGTSS online or score yourself?
Questionnaires and tic diaries can help a person describe their experiences, but the YGTSS is intended to be administered and interpreted by a trained rater. Reproducing a scoring grid on a website does not recreate the semistructured interview, operational definitions, experience in distinguishing tic types, or broader clinical assessment.
A self-assigned number may be useful as an informal record of a person’s impression, provided it is not represented as an official YGTSS result. If you are preparing for an appointment, a practical alternative is to document which movements or sounds occur, when they began, situations in which they change, pain or injury, interference with activities, and the experiences that matter most to you. A clinician can then decide which structured measures are appropriate.
Does the YGTSS diagnose Tourette syndrome?
No. Tourette syndrome is diagnosed by clinical history and diagnostic criteria, including multiple motor tics and at least one vocal tic at some point during the illness, a course of more than one year since the first tic, onset before age 18, and exclusion of certain other causes. Motor and vocal tics do not need to occur simultaneously. Other tic diagnoses depend partly on symptom type and duration. The CDC diagnostic overview explains these distinctions.
The YGTSS does not replace questions about age at onset, lifetime duration, developmental course, substance or medication effects, or alternative movement phenomena. A relatively low score cannot rule out Tourette syndrome, and a high score cannot confirm it. Even a score of zero in a particular recent period cannot by itself settle whether someone has had qualifying motor and vocal tics historically.
There is no single YGTSS cutoff that diagnoses Tourette syndrome, persistent motor or vocal tic disorder, or provisional tic disorder. A clinical diagnosis and a severity measurement answer separate questions: what condition best explains the pattern, and how severe are the relevant current symptoms?
Does the scale distinguish tics from compulsions, stimming, or seizures?
A YGTSS rating presupposes that a clinician has made a reasoned determination about the phenomenon being rated. Motor tics may be brief, recurrent, sometimes preceded by a premonitory urge, and variably suppressible. Compulsions may involve rules, intrusive thoughts, feared outcomes, or efforts to relieve distress. Stereotyped movements and stimming can have different developmental histories, rhythmic or patterned qualities, and sensory functions. Seizure events and other neurological movements may have distinct timing, associated features, or changes in awareness. These are clinical considerations, not rules that classify every behavior from a single observation.
The ESSTS assessment guideline recommends direct clinical assessment and careful differential diagnosis, including awareness of functional tic-like presentations. Functional symptoms are experienced as real and can be involuntary; their presence cannot be established or dismissed from a YGTSS total alone.
For a more detailed discussion of overlapping phenomena, see our already published English articles OCD and Tic Disorders: What Is the Connection? and OCD vs Tourette Syndrome: What Is the Difference?.
What does research say about reliability and validity?
The original Leckman et al. study reported evidence supporting construct, convergent, and discriminant validity. In 2005, a study involving 28 young people with Tourette syndrome found good internal consistency and stability and associations with parent-rated tic severity. That small study was supportive but could not resolve every question about generalizability or measurement precision.
A subsequent 2018 multicenter study examined 617 participants with tic disorders, including 516 children and 101 adults. It found strong internal consistency for motor, vocal, and total tic scores, but also noted that some rating categories were used unevenly. Those patterns motivated targeted revisions to the wording of scale anchors.
A more extensive 2021 analysis using 706 children and adolescents from EMTICS found acceptable convergent validity and good discriminant validity against several other symptom dimensions, with a moderate relationship to a separate global tic rating. However, its internal-consistency estimate for the total score was only acceptable, and confirmatory factor analysis had a marginal fit. This is relevant because a scale can be clinically useful while still leaving meaningful psychometric questions open. Calling the YGTSS a “gold standard” describes its standing among available tools, not perfect accuracy in every context.
What changed in the YGTSS-R?
The revised Yale Global Tic Severity Scale (YGTSS-R) was developed to improve how clinicians apply certain rating anchors. The research team assessed how often different category ratings were selected, identified skewed item distributions, and used expert consensus to refine selected response descriptions. The architecture of motor and vocal ratings, the five symptom domains, and the main score ranges remain familiar. See McGuire et al. (2018).
Revisions to anchors for frequency and complexity are especially relevant because different descriptions can affect where a patient falls on a 0–5 scale. The ESSTS guideline recommends the YGTSS-R. It is useful to record whether a clinic or trial used the original or revised version before comparing results from different settings or years.
The revised scale does not create a diagnostic cutoff and does not eliminate the need for trained clinical judgment. Research comparing the versions and examining measurement properties across languages and populations remains important.
Using YGTSS to track treatment response
Clinicians and researchers commonly record a baseline YGTSS Total Tic Score and reassess it after an intervention, such as Comprehensive Behavioral Intervention for Tics (CBIT) or medication treatment when clinically indicated. Repeated measurement can help answer whether observed tic severity has changed, while impairment and patient-reported outcomes clarify whether the change made a difference in daily life. The American Academy of Neurology practice guideline recommends treatment choices in the context of tic-related functional impairment and patient preferences.
Suppose a patient’s TTS changes from 30 to 21. That is a nine-point reduction or 30% improvement relative to baseline. A researcher may use this as part of an outcome analysis, but an individual clinician should also review adverse effects, pain, sleep, school or workplace participation, satisfaction, and whether other difficulties have become more prominent. Scores can decrease even when the person still requires substantial support.
Treatment is not automatically necessary for every tic. The importance of intervention depends on discomfort, injury, distress, impairment, goals, available services, and shared decision-making. The YGTSS assists this conversation; it does not select a medication dose or declare that an intervention is appropriate.
Is a 25% decrease a meaningful improvement?
A 2013 study of 232 participants in behavioral-treatment trials found that a reduction of about 25% in the Total Tic Score was useful for predicting improvement rated by clinicians. A 2025 analysis of 133 children and adolescents receiving pharmacotherapy also identified percentage changes around this magnitude as helpful, with estimates varying by the external anchor and statistical method.
These findings support group-level interpretation of treatment response under the studied conditions. A 25% reduction is not a universal individual recovery threshold, a diagnostic boundary, or proof that an intervention worked for every patient. Baseline severity, the intervention studied, rater training, assessment interval, fluctuations in symptoms, and changes in functional impairment all matter. A percentage change from a very small baseline can also be unstable or misleading.
Does a better YGTSS score mean quality of life improved?
Often the two move together, but they need not. Reduced tic severity can improve some people’s comfort and participation; another person may continue to face stigma, anxiety, obsessive-compulsive symptoms, attention problems, or social strain even after tic frequency improves. Likewise, environmental accommodations and stronger social support may improve daily life without a proportional change in tic severity. The ESSTS assessment guideline specifically recommends looking beyond tics to coexisting conditions and psychosocial functioning.
What the YGTSS does not measure well
The YGTSS provides a detailed rating of tic phenomena. Its scope does not extend equally to every issue that matters clinically. It does not independently diagnose ADHD, obsessive-compulsive disorder, autism, anxiety, depression, a seizure disorder, or functional neurological disorder. These conditions require their own evaluation pathways and, where appropriate, validated instruments.
It also does not directly measure the full subjective burden of premonitory urges, a person’s attitudes toward their tics, stigma, bullying, sensory experiences, fatigue, school access, interpersonal safety, or general quality of life. Other questionnaires and interviews may address some of these domains, but clinicians still need to consider what a particular measure captures and what it leaves out.
A measure focused on tic severity can underrepresent the experience of someone whose principal difficulties arise from pain, social exposure, or circumstances in which a rare but disruptive tic has serious consequences. Conversely, high tic counts need not mean the individual wants tic reduction to be the top treatment priority. Clinically useful evaluation includes the individual’s own account of need.
Important limitations in practice and research
Tics vary by time, situation, and attention
Tics can fluctuate over hours, days, weeks, and longer periods. They may be suppressed temporarily or expressed differently in a clinic from home or school. The ESSTS recommendations encourage clinicians to combine observation, history, and appropriate informants when making an assessment. A single score must be placed in context.
Ratings depend on consistent interviewing and training
Although YGTSS domains have anchor descriptions, a clinician still needs to recognize tic phenomenology and apply definitions consistently. Differences in rater experience, recall, informant reports, language, and cultural context may affect ratings. The 2018 refinements themselves arose from evidence that some category anchors were not performing optimally in multicenter data.
Motor and vocal tics are not identical dimensions
Two people with the same total may have very different motor-vocal profiles. Reporting the motor and vocal scores separately can help reveal the pattern. The numerical total summarizes severity in a particular way and cannot replace descriptions of which tics cause the most problems.
The global total blends severity and impairment
The global score adds two clinically relevant but distinct constructs. The EMTICS psychometric paper concluded that using the Total Tic Score and impairment rating separately was more beneficial than relying on the global sum alone.
Research populations and settings differ
Validation studies have used different ages, recruitment procedures, clinical presentations, and assessment versions. A reported correlation, reliability statistic, or proposed response threshold from one study cannot automatically be applied to all adults, preschool children, people with overlapping neurodevelopmental conditions, or people with functional tic-like presentations.
The score is not a biological measure
A YGTSS result describes clinically assessed symptoms and impairment. It does not establish a gene, neurotransmitter abnormality, brain lesion, causal mechanism, or prognosis. Neuroimaging and laboratory tests are used for other clinical indications where appropriate, but they do not convert a YGTSS score into a direct biological test.
YGTSS compared with other assessment tools
The Premonitory Urge for Tics Scale (PUTS) addresses subjective sensory experiences that can precede tics. It offers information about urges that is distinct from the clinician-rated severity of visible or audible tics. Development and age can affect how easily a person identifies or reports these sensations.
The Clinical Global Impression instruments provide broader clinician judgments of overall severity or improvement; they are often used alongside YGTSS in trials. A global impression does not reproduce the five-dimension tic assessment.
Video-based tic ratings can help quantify features observed during a defined recording, while diaries and patient or parent questionnaires can contribute accounts from everyday settings. These tools differ in observation windows, response formats, purposes, and evidence for validity. The ESSTS guideline’s assessment tables describe recommended and alternative instruments, including the YGTSS, PUTS, parent and adult tic questionnaires, and video-based approaches.
Scales developed for OCD, such as the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), address obsessions and compulsions rather than tic severity. The similarity of the names reflects the historical naming of the instruments, not interchangeability. Clinicians may use both sets of measures when tics and OCD symptoms coexist, while maintaining separate clinical diagnostic and outcome evaluations.
How patients and families can make a YGTSS assessment more useful
It helps to bring examples of current tics, approximate age of onset, situations in which symptoms change, and a description of how they affect school, work, relationships, sleep, comfort, or safety. The person being assessed can identify which symptoms feel most troubling and whether treatment goals focus on pain relief, fewer interruptions, less stigma, better participation, or another outcome.
For a child, caregivers can supply history while also making space for the child’s perspective. For an adult, a partner’s observations may be useful if the person wants that involvement. Any recordings should be made and shared with consent and attention to privacy. The key purpose is to improve the accuracy of the account, including symptoms that may not appear during the visit.
A useful follow-up question is not simply “Did the score fall?” but “What actually changed in daily life, what remains difficult, and what goals matter now?” That interpretation is consistent with the AAN treatment recommendations and with the broader assessment framework recommended by ESSTS.
Frequently asked questions
What does YGTSS stand for?
YGTSS stands for Yale Global Tic Severity Scale. It is a clinician-rated instrument for tic symptom severity and tic-related impairment.
Is YGTSS a diagnostic test for Tourette syndrome?
No. Diagnostic criteria require information about motor and vocal tics, onset, duration, and alternative causes. The YGTSS quantifies recent symptom severity within that wider clinical assessment.
What is the maximum YGTSS score?
The combined motor and vocal Total Tic Score reaches 50. Overall Impairment reaches 50. The combined Global Severity Score reaches 100.
What does a YGTSS score of 30 mean?
It depends on which score is being reported. Thirty out of 50 on the Total Tic Score is different from 30 out of 100 on the Global Severity Score or 30 out of 50 for impairment. The result must be labeled, reviewed against its component ratings, and interpreted by a clinician.
Does a higher score mean more tics?
A higher Total Tic Score generally indicates greater rated tic severity, based on number, frequency, intensity, complexity, and interference. It does not directly equal a count of tic episodes or different tic types.
Can someone have Tourette syndrome with a low YGTSS score?
Yes. Tourette syndrome criteria concern the pattern and history of tics. Current severity varies, and the person may experience a relatively mild period during assessment.
Can the YGTSS measure vocal tics without motor tics?
The instrument has separate vocal and motor symptom sections. A clinician can rate the vocal tic domain independently of the motor tic domain, while making the diagnostic determination separately.
How long does the YGTSS take?
Time depends on the complexity of the history and whether the scale is integrated into a broader assessment. The ESSTS guideline includes approximately 15 minutes for the severity-rating component in its illustrative assessment schedule; an initial clinical evaluation may require substantially more time.
Is the YGTSS-R different from the YGTSS?
The revised version retains the overall assessment framework and score ranges but refines selected scoring anchors. When comparing scores over time or across studies, it is best to know which version was administered.
Is a 25% reduction a treatment success?
Research in particular trial populations has found a reduction around 25% to be a useful indicator of improvement. Clinical success also depends on impairment, the person’s goals, coexisting conditions, treatment burden, and the setting in which change was measured.
Can YGTSS distinguish Tourette syndrome from functional tic-like symptoms?
The scale alone cannot. A clinician must assess the presentation, onset, course, phenomenology, context, and relevant differential diagnoses. Functional symptoms are real clinical experiences and require an appropriate assessment.
Is YGTSS appropriate for both children and adults?
It has been used in both groups, and the original and subsequent research include children and adults. Questions about psychometric performance, informant input, and version-specific comparability still depend on the group and setting.
Related Articles
References
American Academy of Neurology (AAN). Pringsheim, T., et al. (2019). Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology, 92, 896–906. https://doi.org/10.1212/WNL.0000000000007466
Centers for Disease Control and Prevention (CDC). (2026). Diagnosing Tic Disorders. https://www.cdc.gov/tourette-syndrome/diagnosis/index.html
Haas, M., et al. (2021). Yale Global Tic Severity Scale (YGTSS): Psychometric quality of the gold standard for tic assessment based on the large-scale EMTICS study. Frontiers in Psychiatry, 12, 626459. https://doi.org/10.3389/fpsyt.2021.626459
Leckman, J. F., et al. (1989). The Yale Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity. Journal of the American Academy of Child & Adolescent Psychiatry, 28, 566–573. https://doi.org/10.1097/00004583-198907000-00015
McGuire, J. F., et al. (2013). Detecting a clinically meaningful change in tic severity in Tourette syndrome: A comparison of three methods. Contemporary Clinical Trials, 36, 414–420. https://doi.org/10.1016/j.cct.2013.08.012
McGuire, J. F., et al. (2018). A multicenter examination and strategic revisions of the Yale Global Tic Severity Scale. Neurology, 90, e1711–e1719. https://doi.org/10.1212/WNL.0000000000005474
McGuire, J. F., et al. (2025). Determining clinically meaningful improvement in children and adolescents with Tourette syndrome receiving pharmacotherapy. Journal of Child and Adolescent Psychopharmacology, 35, 447–453. https://doi.org/10.1089/cap.2025.0036
Storch, E. A., et al. (2005). Reliability and validity of the Yale Global Tic Severity Scale. Psychological Assessment, 17, 486–491. https://doi.org/10.1037/1040-3590.17.4.486
Szejko, N., et al. (2022). European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part I: Assessment. European Child & Adolescent Psychiatry, 31, 383–402. https://doi.org/10.1007/s00787-021-01842-2